Tissue Diagnostics Market worth $10.86 billion by 2030 | MarketsandMarkets™
DELRAY BEACH, Fla., Feb. 10, 2026 /PRNewswire/ — According to MarketsandMarkets
, the Tissue Diagnostics Market is projected to grow from about USD 6.74 billion in 2025 to USD 10.86 billion by 2030, at a CAGR of 10.0%.
Browse 568 market data Tables and 54 Figures spread through 420 Pages and in-depth TOC on “Tissue Diagnostics Market – Global Forecast to 2030”
Tissue Diagnostics Market Size & Forecast:
- Market Size Available for Years: 2024–2030
- 2025 Market Size: USD 6.74 billion
- 2030 Projected Market Size: USD 10.86 billion
- CAGR (2026–2031): 10.0%
Tissue Diagnostics Market Trends & Insights:
- The tissue diagnostics market is segmented into immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology, special staining, and other technologies, with IHC leading the market.
- The tissue diagnostics market is segmented into consumables, instruments, software, and services, with consumables accounting for the largest share.
- The tissue diagnostics market is segmented by region into North America, Europe, Asia Pacific, South America, the Middle East, and Africa. North America leads the market.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1063949
The rising incidence of cancer and the growing demand for digital pathology solutions are among the major factors driving market expansion. With cancer cases increasing worldwide, there is a heightened focus on early and accurate disease diagnosis through advanced tissue analysis techniques. Simultaneously, the growing adoption of digital pathology is transforming traditional laboratory workflows by improving slide management, enabling remote consultations, and supporting data-driven diagnostic decisions. These trends, combined with continuous technological advancements and rising healthcare investments, are expected to strengthen the market’s growth trajectory over the coming years.
Emerging technological innovations are set to transform the business landscape of the tissue diagnostics market by driving a shift toward automation, digitization, and precision-based testing. The growing integration of digital pathology platforms and whole-slide imaging systems is enabling remote diagnostics and AI-assisted analysis, improving scalability and global collaboration. Advancements in multiplex IHC, in situ hybridization (ISH), and molecular profiling technologies are expanding the scope of biomarker discovery and personalized oncology diagnostics. Moreover, next-generation instruments with enhanced connectivity and workflow automation are streamlining operations across clinical and research laboratories. These developments are pushing companies to modernize product portfolios, adopt interoperable solutions, and invest in R&D to maintain competitiveness in a rapidly evolving diagnostic ecosystem.
By product & service, the consumables segment accounted for the largest share of the tissue diagnostics market in 2024.
The global tissue diagnostics market is divided into consumables, instruments, software, and services. The consumables segment dominated the tissue diagnostics market in 2024. This segment includes antibodies, reagents, kits, probes, and other essential laboratory consumables that are routinely used in tissue analysis workflows. The dominance of consumables can be attributed to their recurring demand in diagnostic and research laboratories, as they are required for every assay and test. Additionally, the increasing adoption of automated and high-throughput tissue diagnostic systems has further amplified the need for standardized and high-quality consumables, making this segment a key contributor to market growth.
Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=1063949
By end user, the hospitals segment accounted for the largest share of the tissue market in 2024.
The tissue diagnostics market is segmented into hospitals, research laboratories, pharmaceutical companies, contract research organizations (CROs), and other end users. Hospitals accounted for the largest share of the market, reflecting their central role in clinical diagnostics and patient care. The high patient volume, increasing prevalence of cancer and other tissue-related diseases, and growing adoption of advanced tissue diagnostic systems in hospital pathology labs drive this dominance. Hospitals rely on these technologies for accurate diagnosis, treatment planning, and monitoring, making them the primary consumers of tissue diagnostics products and services.
North America represents the largest regional tissue diagnostics market.
North America held the largest share of the global tissue diagnostics market in 2024, driven by well-established healthcare infrastructure, high-quality laboratory facilities, and significant healthcare expenditure. The region benefits from widespread adoption of advanced diagnostic technologies, including automated tissue processing systems, digital pathology, and high-throughput immunohistochemistry platforms. Additionally, the presence of leading market players, robust R&D activities, and supportive regulatory frameworks contributes to the strong demand for tissue diagnostics solutions across hospitals, research laboratories, and private diagnostic centers in North America.
Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=1063949
Top Companies in Tissue Diagnostics Market:
The Top Companies in Medical Simulation Market include F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), PHC Holdings Corporation (Japan), Merck KGAa (Germany), and Agilent Technologies (US).
Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting
Related Reports:
Molecular Diagnostics Market – Global Forecast to 2030
In Vitro Diagnostics Market – Global Forecast to 2030
In Situ Hybridization Market – Global Forecast to 2030
Immunohistochemistry Market – Global Forecast to 2030
Point of Care Diagnostics Market – Global Forecast to 2029
About MarketsandMarkets
MarketsandMarkets has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.
MarketsandMarkets SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.
To find out more, visit www.MarketsandMarkets.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/tissue-diagnostics-market-worth-10-86-billion-by-2030–marketsandmarkets-302683328.html
SOURCE MarketsandMarkets
You May Also Like
From Early Trading Losses to Global Impact: Somesh’s Journey to Building an Int’l Trading Community
Bitcoin and Ethereum prices to crash after FOMC, top analyst warns
